Genital Warts: GUM, Singapore (SG) | HIV STD TESTING TREATMENT™
Genital Warts: GUM, Singapore (SG) | HIV STD TESTING TREATMENT™ @singaporegum_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.
Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts: GUM, Singapore (SG)
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: half hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
(of HIV/STD/pregnancy), and what you can do before and after exposure.
Lower cost strategies for triage of human papillomavirus DNA‐positive women
Tue, 03 Dec 2013 05:00:00 +0100 | International Journal of Cancer
Using human papillomavirus (HPV) testing for cervical cancer screening in lower‐resource settings (LRS) will result in a significant number of screen‐positive women. This analysis compares different triage strategies for detecting cervical precancer and cancer among HPV‐positive women in LRS. This was a population‐based study of women aged 25–65 years living in China (n = 7,541). Each woman provided a self‐collected and two clinician‐collected specimens. The self‐collected and one clinician‐collected specimen were tested by two HPV DNA tests—careHPV™ and Hybrid Capture 2; the other clinician‐collected specimen was tested for HPV16/18/45 E6 protein. CareHPV™‐positive specimens were tested for HPV16/18/45 DNA. HPV DNA‐positive women underwent visual inspecti...
Content analysis of continuing education for cervical cytology
Tue, 03 Dec 2013 05:00:00 +0100 | International Journal of Evidence-Based Healthcare
ConclusionsThe correct information on age‐appropriate screening intervals and HPV co‐testing was included in the continuing education activities reviewed. The areas that were largely underrepresented in the continuing education activities were the risk factors, prevention measures for transmission of HPV, patient counselling about HPV and the appropriate screening practices. (Source: International Journal of Evidence-Based Healthcare)
HIV plus HPV leads to increased anal cancer risk in men
Mon, 02 Dec 2013 22:50:03 +0100 | UCLA Newsroom: Health Sciences
This study highlights the benefit of adhering to HIV treatment, which among HIV-infected men who have sex with men, is important for cancer-prevention strategies," Wiley said.
Is Colposcopy necessary at twelve months after large loop excision of the transformation zone? A clinical audit
Mon, 02 Dec 2013 05:00:00 +0100 | The Australian and New Zealand Journal of Obstetrics and Gynaecology
ConclusionColposcopy examination is an insensitive tool for detection of persisting HPV‐related change after excision of high‐grade CIN. Its usefulness to investigate persistent or recurrent HSIL is further reduced by the high rate of unsatisfactory colposcopy examinations after a LLETZ procedure. Papanicolaou smear and HRHPV tests may be adequate follow‐up at 12 months after LLETZ for women at low risk of recurrence of HSIL. (Source: The Australian and New Zealand Journal of Obstetrics and Gynaecology)
Utility of P16 expression and Ki‐67 proliferation index in ASCUS and ASC‐H pap tests
Sun, 01 Dec 2013 05:00:00 +0100 | Diagnostic Cytopathology
Acute chorea in a child receiving second dose of human papilloma virus vaccine
Sun, 01 Dec 2013 05:00:00 +0100 | Pediatric Allergy and Immunology
(Source: Pediatric Allergy and Immunology)
Cervical adenocarcinoma identification by testing for chromosomal abnormalities.
Sun, 01 Dec 2013 05:00:00 +0100 | Archives of Pathology and Laboratory Medicine
We report on a case of cervical adenocarcinoma in situ in a 42-year-old woman with a history of human papillomavirus infection. Repeat cytology, human papillomavirus testing, and colposcopy failed to identify the lesion. Testing of the cervical cell DNA identified chromosomal abnormalities, prompting a cervical cone biopsy, which identified adenocarcinoma in situ.
HPV vaccine could be offered to boys
Fri, 29 Nov 2013 12:00:00 +0100 | NHS News Feed
"HPV vaccine could be given to boys as well as girls in UK," The Guardian reports.
Regulatory Update - GSK receives positive CHMP opinion for Cervarix™ two-dose schedule
Thu, 28 Nov 2013 11:18:11 +0100 | GSK news
Today, GlaxoSmithKline plc (GSK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is recommending marketing authorisation for a two-dose schedule in 9-14 year old girls for its cervical cancer vaccine, Cervarix™ [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant]. (Source: GSK news)
Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
Thu, 28 Nov 2013 05:00:00 +0100 | Journal of Cellular and Molecular Medicine